// App-Quantinova.ai

e21635 : Clinical benefits and risks associated with darbepoetin alfa and epoetin alfa treatment in patients with lung cancer and chemotherapy-induced anemia.

Researchers

Presenter

  • Angelica Tiotiu

Principal Investigators

  • Isabelle Clerc-Urmes

  • Francois Chabot

  • Yves Martinet

Medical Centers

  • University Hospital of Lille, Lille, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Anemia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Darbepoetin alfa

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved